Nanoform Launches Sparse-Data AI Solution
Nanoform Finland has launched STARMAP Online—a sparse-data artificial intelligence (AI) solution that it is using as a secure online portal for direct use by the company’s current and future partners.
Innovative nanoparticle medicine-enabling company, Nanoform Finland, has launched STARMAP Online—a sparse-data artificial intelligence (AI) solution that it is using as a secure online portal for direct use by the company’s current and future partners.
The company, which announced the launch in a May 4, 2022 press release, has been using the product to provide clients with an assessment of whether their molecules are suitably stable for use with the Controlled Expansion of Supercritical Solutions (CESS) nanoparticle engineering. The AI solution is a digital version of the CESS technology, which provides a determination of whether molecules should be nanoformed through in-silico experiments.
“STARMAP Online opens up new galaxies of potential, and we are excited to increase access for the pharma community. The technology has a significant potential impact, allowing viable CESS candidates to be rapidly identified. STARMAP Online has the potential to transform the lives of patients by accelerating the development of new therapies, supporting our mission to touch the lives of a billion patients with nanoformed medicines,” said Prof. Edward Hæggström, CEO of Nanoform, in the press release.
Source: Nanoform
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.
